Connect with us

Health

Sacubitril/valsartan drug did not significantly reduce cardiovascular death after heart attack – News-Medical.Net

The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to…

Published

on

Article feature image
ADVERTISEMENT

The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to ramipril, an angiotensin-converting enzyme(ACE)inhibitor proven effective in improving survival following heart attacks. Findings from the PARADISE-MI trial were presented at the American College of Cardiologys 70thAnnual Scientific Session.
The study is the first large trial to examine whether sacubitril/valsartan can reduce heart failure…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
New treatment stops progression of Alzheimer’s disease in monkey brains – EurekAlert
Article feature image
New wound gap closure mechanism may offer faster, better healing after injury or surgery – News-Medical.net